Auxier Asset Management Abbott Laboratories Transaction History

Auxier Asset Management

$672 Million
Q3 2024

A detailed history of Auxier Asset Management transactions in Abbott Laboratories stock. As of the latest transaction made, Auxier Asset Management holds 71,039 shares of ABT stock, worth $8.38 Million. This represents 1.21% of its overall portfolio holdings.

Number of Shares

71,039

Previous 71,080 0.06%

Holding current value

$8.38 Million

Previous $7.39 Million 9.67%

% of portfolio

1.21%

Previous 1.18%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$100.07 - $118.13 $4,102 - $4,843	-41 Reduced 0.06%	71,039 $8.1 Million
Q2 2024 Aug 13, 2024	SELL	$100.73 - $112.44 $2,014 - $2,248	-20 Reduced 0.03%	71,080 $7.39 Million
Q1 2024 May 08, 2024	SELL	$109.52 - $120.96 $168,441 - $186,036	-1,538 Reduced 2.12%	71,100 $8.08 Million
Q4 2023 Feb 22, 2024	SELL	$90.19 - $110.4 $72,963 - $89,313	-809 Reduced 1.1%	72,638 $8 Million
Q3 2023 Nov 21, 2023	SELL	$95.53 - $114.62 $123,711 - $148,432	-1,295 Reduced 1.73%	73,447 $7.11 Million
Q2 2023 Aug 17, 2023	BUY	$100.78 - $112.29 $238,949 - $266,239	2,371 Added 3.28%	74,742 $8.15 Million
Q1 2023 May 15, 2023	SELL	$96.86 - $114.01 $271,982 - $320,140	-2,808 Reduced 3.74%	72,371 $7.33 Million
Q4 2022 Feb 17, 2023	SELL	$95.06 - $111.52 $15,114 - $17,731	-159 Reduced 0.21%	75,179 $8.26 Million
Q3 2022 Nov 15, 2022	SELL	$96.76 - $112.03 $91,922 - $106,428	-950 Reduced 1.25%	75,338 $7.29 Million
Q2 2022 Aug 11, 2022	SELL	$102.07 - $123.37 $101,967 - $123,246	-999 Reduced 1.29%	76,288 $8.29 Million
Q1 2022 May 17, 2022	SELL	$114.02 - $139.04 $2,166 - $2,641	-19 Reduced 0.02%	77,287 $9.15 Million
Q4 2021 Mar 01, 2022	SELL	$115.53 - $141.46 $491,695 - $602,053	-4,256 Reduced 5.22%	77,306 $10.9 Million
Q3 2021 Nov 18, 2021	SELL	$116.66 - $129.06 $312,415 - $345,622	-2,678 Reduced 3.18%	81,562 $9.64 Million
Q2 2021 Aug 18, 2021	SELL	$105.79 - $124.53 $95,739 - $112,699	-905 Reduced 1.06%	84,240 $9.77 Million
Q1 2021 May 17, 2021	SELL	$108.84 - $128.23 $70,528 - $83,093	-648 Reduced 0.76%	85,145 $10.2 Million
Q4 2020 Mar 05, 2021	SELL	$105.0 - $114.42 $43,575 - $47,484	-415 Reduced 0.48%	85,793 $9.39 Million
Q3 2020 Mar 05, 2021	SELL	$91.64 - $111.29 $159,178 - $193,310	-1,737 Reduced 1.98%	86,208 $9.38 Million
Q2 2020 Aug 20, 2020	SELL	$76.57 - $98.0 $425,116 - $544,096	-5,552 Reduced 5.94%	87,945 $8.04 Million
Q1 2020 May 15, 2020	SELL	$62.82 - $91.86 $248,390 - $363,214	-3,954 Reduced 4.06%	93,497 $7.38 Million
Q4 2019 Feb 21, 2020	SELL	$78.51 - $87.4 $17,978 - $20,014	-229 Reduced 0.23%	97,451 $8.47 Million
Q3 2019 Nov 15, 2019	BUY	$81.84 - $88.74 $24,552 - $26,622	300 Added 0.31%	97,680 $8.17 Million
Q2 2019 Aug 15, 2019	SELL	$72.88 - $85.0 $76,451 - $89,165	-1,049 Reduced 1.07%	97,380 $8.19 Million
Q1 2019 May 14, 2019	SELL	$66.22 - $80.06 $127,738 - $154,435	-1,929 Reduced 1.92%	98,429 $7.87 Million
Q4 2018 Feb 13, 2019	SELL	$65.56 - $74.27 $78,606 - $89,049	-1,199 Reduced 1.18%	100,358 $7.26 Million
Q3 2018 Nov 19, 2018	SELL	$60.81 - $73.36 $18,182 - $21,934	-299 Reduced 0.29%	101,557 $7.45 Million
Q2 2018 Aug 15, 2018	SELL	$57.57 - $63.54 $131,202 - $144,807	-2,279 Reduced 2.19%	101,856 $6.21 Million
Q1 2018 May 14, 2018	SELL	$56.27 - $63.62 $14,123 - $15,968	-251 Reduced 0.24%	104,135 $6.24 Million
Q4 2017 Feb 14, 2018	SELL	$53.68 - $57.47 $202,856 - $217,179	-3,779 Reduced 3.49%	104,386 $5.96 Million
Q3 2017 Nov 09, 2017	SELL	$48.06 - $53.64 $7,160 - $7,992	-149 Reduced 0.14%	108,165 $5.77 Million
Q2 2017 Aug 16, 2017	BUY	N/A	108,314	108,314 $5.27 Million

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $207B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Auxier Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Auxier Asset Management with notifications on news.

Account

Auxier Asset Management Abbott Laboratories Transaction History